2020 annual financial data

Compass Therapeutics 2020 Net income growth

Direct answer

Net income growth was 15.09%.

Operating income was -27,812,000 USD and net income was -29,500,000 USD.
Operating cash flow was -26,803,000 USD.

Get free Compass Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-27,812,000 USD
Net income
-29,500,000 USD
Operating cash flow
-26,803,000 USD